“The Efficacy of Single Dose Palonosetron in Highly Emetogenic Chemotherapy Protocols Compared to Oral Aprepitant and Ondansetron”. Journal of Pharmacovigilance and Drug Research 3, no. 3 (September 1, 2022): 28–39. Accessed October 14, 2026. https://test.jpadr.com/index.php/jpadr/article/view/71.